Your browser doesn't support javascript.
loading
The non-crosslinking fixative RCL2®-CS100 is compatible with both pathology diagnosis and molecular analyses.
Boissière-Michot, Florence; Denouël, Amélie; Boulle, Nathalie; Guillaume, Carole; Orsetti, Béatrice; Lopez-Crapez, Evelyne; Chateau, Marie-Christine; Bibeau, Frédéric.
Affiliation
  • Boissière-Michot F; Department of Pathology, Val d'Aurelle Cancer Institute, Montpellier 34 298, France. Florence.Boissiere@montpellier.unicancer.fr
Pathol Oncol Res ; 19(1): 41-53, 2013 Jan.
Article in En | MEDLINE | ID: mdl-22893391
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nucleic Acids / Molecular Diagnostic Techniques / Fixatives / Histocytochemistry Type of study: Diagnostic_studies / Guideline Limits: Female / Humans Language: En Journal: Pathol Oncol Res Journal subject: NEOPLASIAS / PATOLOGIA Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nucleic Acids / Molecular Diagnostic Techniques / Fixatives / Histocytochemistry Type of study: Diagnostic_studies / Guideline Limits: Female / Humans Language: En Journal: Pathol Oncol Res Journal subject: NEOPLASIAS / PATOLOGIA Year: 2013 Document type: Article Affiliation country: Country of publication: